Similar articles

• Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics.

  Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wüstenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A. Juckel G, et al. Psychopharmacology (Berl). 2006 Aug;187(2):222-8. doi: 10.1007/s00213-006-0405-4. Epub 2006 May 24. Psychopharmacology (Berl). 2006. PMID: 16721614
• Anhedonia, self-experience in schizophrenia, and implications for treatment.

  Juckel G, Sass L, Heinz A. Juckel G, et al. Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S176-80. doi: 10.1055/s-2003-45127. Pharmacopsychiatry. 2003. PMID: 14677076 Review.
• Inhibition of the reward system by antipsychotic treatment.

  Juckel G. Juckel G. Dialogues Clin Neurosci. 2016 Mar;18(1):109-14. doi: 10.31887/DCNS.2016.18.1/gjuckel. Dialogues Clin Neurosci. 2016. PMID: 27069385 Free PMC article. Review.
• Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity.

  Wang J, Huang J, Yang XH, Lui SS, Cheung EF, Chan RC. Wang J, et al. Schizophr Res. 2015 Oct;168(1-2):465-74. doi: 10.1016/j.schres.2015.06.019. Epub 2015 Jul 14. Schizophr Res. 2015. PMID: 26185892
• Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?

  Carnoy P, Soubrie P, Puech AJ, Simon P. Carnoy P, et al. Biol Psychiatry. 1986 Jan;21(1):11-22. doi: 10.1016/0006-3223(86)90004-1. Biol Psychiatry. 1986. PMID: 2867789